Anthem Biosciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
ANTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anthem Biosciences has informed the exchanges that the trading window for its securities will be closed for all designated persons from October 1, 2025, until 48 hours after the upcoming board meeting that will approve financial results for the quarter ending September 30, 2025. This is a standard compliance measure under SEBI's insider trading regulations to prevent insiders from trading while in possession of unpublished financial information. The exact date of the board meeting for the Q2 FY26 results has not yet been announced and will be communicated later.
This is a routine regulatory filing with no direct impact on shareholders. However, it signals that the company's Q2 FY26 financial results will be announced in the coming weeks, which may be a catalyst for stock movement depending on the numbers.